NCT01829126 Development and Prevention of Severe Heart Disease in Systemic Sclerosis Status UNKNOWN Phase N/A
NCT01813578 Effects of Intensive Aerobic and Muscle Endurance Exercise in Patients With Systemic Sclerosis - a Pilot Study Status COMPLETED Phase NA
NCT01813279 Assessment of the Subcutaneous Reinjection of Human Autologous Adipose-derived Stromal Vascular Fraction (Celution® System) in the Hands of Patients Suffering From Systemic Sclerosis Status COMPLETED Phase NA
NCT01804959 Clinical Trial of Probiotics in Systemic Sclerosis Associated Gastrointestinal Disease Status UNKNOWN Phase PHASE2
NCT01670565 Belimumab for the Treatment of Diffuse Cutaneous Systemic Sclerosis Status COMPLETED Phase PHASE2
NCT01651143 Proof of Biological Activity of SAR100842 in Systemic Sclerosis Status COMPLETED Phase PHASE2
NCT01570764 Cyclophosphamide Systemic Sclerosis Associated Interstitial Lung Disease Status COMPLETED Phase PHASE3
NCT01559129 Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Patients With Systemic Sclerosis With Interstitial Lung Disease Status TERMINATED Phase PHASE2
NCT01488214 Neuropsychiatric Scleroderma Study: Systematic Evaluation of Neuropsychiatric Involvement in Systemic Sclerosis Status COMPLETED Phase NA
NCT01487551 An Open-Label Study to Evaluate Biomarkers and Safety in Systemic Sclerosis Patients Treated With ABR-215757 (Paquinimod) Status COMPLETED Phase PHASE2
NCT01474109 Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients Status COMPLETED Phase PHASE3